AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN FOLLICULAR NON-HODGKINS-LYMPHOMA
Authors: FREEDMAN AS GRIBBEN JG NADLER LM
Citation: As. Freedman et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN FOLLICULAR NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 28(3-4), 1998, pp. 219-230
HIGH-DOSE CHEMORADIOTHERAPY AND ANTI-B-CELL MONOCLONAL-ANTIBODY PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MANTLE-CELL LYMPHOMA - NO EVIDENCE FOR LONG-TERM REMISSION
Authors: FREEDMAN AS NEUBERG D GRIBBEN JG MAUCH P SOIFFER RJ FISHER DC ANDERSON KC ANDERSEN N SCHLOSSMAN R KROON M RITZ J ASTER J NADLER LM
Citation: As. Freedman et al., HIGH-DOSE CHEMORADIOTHERAPY AND ANTI-B-CELL MONOCLONAL-ANTIBODY PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN MANTLE-CELL LYMPHOMA - NO EVIDENCE FOR LONG-TERM REMISSION, Journal of clinical oncology, 16(1), 1998, pp. 13-18
CD6(-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA() T)
Authors: SOIFFER RJ FREEDMAN AS NEUBERG D FISHER DC ALYEA EP GRIBBEN J SCHLOSSMAN RL BARTLETTPANDITE L KUHLMAN C MURRAY C FREEMAN A MAUCH P ANDERSON KC NADLER LM RITZ J
Citation: Rj. Soiffer et al., CD6(-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA() T), Bone marrow transplantation, 21(12), 1998, pp. 1177-1181
PREDICTIVE VALUE OF CLONALITY ASSAYS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANT - A SINGLE INSTITUTION STUDY
Authors: MACHPASCUAL S LEGARE RD LU D KROON M NEUBERG D TANTRAVAHI R STONE RM FREEDMAN AS NADLER LM GRIBBEN JG GILLILAND DG
Citation: S. Machpascual et al., PREDICTIVE VALUE OF CLONALITY ASSAYS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANT - A SINGLE INSTITUTION STUDY, Blood, 91(12), 1998, pp. 4496-4503
UNBALANCED EXPRESSION OF BCL-2 FAMILY PROTEINS IN FOLLICULAR LYMPHOMA- CONTRIBUTION OF CD40 SIGNALING IN PROMOTING SURVIVAL
Authors: GHIA P BOUSSIOTIS VA SCHULTZE JL CARDOSO AA DORFMAN DM GRIBBEN JG FREEDMAN AS NADLER LM
Citation: P. Ghia et al., UNBALANCED EXPRESSION OF BCL-2 FAMILY PROTEINS IN FOLLICULAR LYMPHOMA- CONTRIBUTION OF CD40 SIGNALING IN PROMOTING SURVIVAL, Blood, 91(1), 1998, pp. 244-251
ASSOCIATION OF THE CAS-LIKE MOLECULE HEF1 WITH CRKL FOLLOWING INTEGRIN AND ANTIGEN RECEPTOR SIGNALING IN HUMAN B-CELLS - POTENTIAL RELEVANCE TO NEOPLASTIC LYMPHOHEMATOPOIETIC CELLS
Authors: ASTIER A MANIE SN LAW SF CANTY T HAGHAYGHI N DRUKER BJ SALGIA R GOLEMIS EA FREEDMAN AS
Citation: A. Astier et al., ASSOCIATION OF THE CAS-LIKE MOLECULE HEF1 WITH CRKL FOLLOWING INTEGRIN AND ANTIGEN RECEPTOR SIGNALING IN HUMAN B-CELLS - POTENTIAL RELEVANCE TO NEOPLASTIC LYMPHOHEMATOPOIETIC CELLS, Leukemia & lymphoma, 28(1-2), 1997, pp. 65-72
TYROSINE PHOSPHORYLATION OF THE PRODUCT OF THE C-CBL PROTOONCOGENESISINDUCED AFTER INTEGRIN STIMULATION
Authors: MANIE SN SATTLER M ASTIER A PHIFER JS CANTY T MORIMOTO C DRUKER BJ SALGIA R GRIFFIN JD FREEDMAN AS
Citation: Sn. Manie et al., TYROSINE PHOSPHORYLATION OF THE PRODUCT OF THE C-CBL PROTOONCOGENESISINDUCED AFTER INTEGRIN STIMULATION, Experimental hematology, 25(1), 1997, pp. 45-50
INVOLVEMENT OF P130(CAS) AND P105(HEF1), A NOVEL CAS-LIKE DOCKING PROTEIN, IN A CYTOSKELETON-DEPENDENT SIGNALING PATHWAY INITIATED BY LIGATION OF INTEGRIN OR ANTIGEN RECEPTOR ON HUMAN B-CELLS
Authors: MANIE SN BECK ARP ASTIER A LAW SF CANTY T HIRAI H DRUKER BJ AVRAHAM H HAGHAYEGHI N SATTLER M SALGIA R GRIFFIN JD GOLEMIS EA FREEDMAN AS
Citation: Sn. Manie et al., INVOLVEMENT OF P130(CAS) AND P105(HEF1), A NOVEL CAS-LIKE DOCKING PROTEIN, IN A CYTOSKELETON-DEPENDENT SIGNALING PATHWAY INITIATED BY LIGATION OF INTEGRIN OR ANTIGEN RECEPTOR ON HUMAN B-CELLS, The Journal of biological chemistry, 272(7), 1997, pp. 4230-4236
THE RELATED ADHESION FOCAL TYROSINE KINASE DIFFERENTIALLY PHOSPHORYLATES P130(CAS) AND THE CAS-LIKE PROTEIN, P105(HEF1)
Authors: ASTIER A MANIE SN AVRAHAM H HIRAI H LAW SF ZHANG YH GOLEMIS EA FU YG DRUKER BJ HAGHAYEGHI N FREEDMAN AS AVRAHAM S
Citation: A. Astier et al., THE RELATED ADHESION FOCAL TYROSINE KINASE DIFFERENTIALLY PHOSPHORYLATES P130(CAS) AND THE CAS-LIKE PROTEIN, P105(HEF1), The Journal of biological chemistry, 272(32), 1997, pp. 19719-19724
REGULATION OF INTEGRIN-MEDIATED P130(CAS) TYROSINE PHOSPHORYLATION INHUMAN B-CELLS - A ROLE FOR P59(FYN) AND SHP2
Authors: MANIE SN ASTIER A HAGHAYEGHI N CANTY T DRUKER BJ HIRAI H FREEDMAN AS
Citation: Sn. Manie et al., REGULATION OF INTEGRIN-MEDIATED P130(CAS) TYROSINE PHOSPHORYLATION INHUMAN B-CELLS - A ROLE FOR P59(FYN) AND SHP2, The Journal of biological chemistry, 272(25), 1997, pp. 15636-15641
THE RELATED ADHESION FOCAL TYROSINE KINASE IS TYROSINE-PHOSPHORYLATEDAFTER BETA-1-INTEGRIN STIMULATION IN B-CELLS AND BINDS TO P130(CAS)
Authors: ASTIER A AVRAHAM H MANIE SN GROOPMAN J CANTY T AVRAHAM S FREEDMAN AS
Citation: A. Astier et al., THE RELATED ADHESION FOCAL TYROSINE KINASE IS TYROSINE-PHOSPHORYLATEDAFTER BETA-1-INTEGRIN STIMULATION IN B-CELLS AND BINDS TO P130(CAS), The Journal of biological chemistry, 272(1), 1997, pp. 228-232
LYMPHOMA-CELLS DISPLAY DEFECTIVE REGULATION OF DEATH EFFECTOR PROTEINS POTENTIALLY CONTRIBUTING TO THEIR RESISTANCE TO TREATMENT
Authors: GHIA P BOUSSIOTIS VA CARDOSO AA FREEDMAN AS NADLER LM
Citation: P. Ghia et al., LYMPHOMA-CELLS DISPLAY DEFECTIVE REGULATION OF DEATH EFFECTOR PROTEINS POTENTIALLY CONTRIBUTING TO THEIR RESISTANCE TO TREATMENT, Blood, 90(10), 1997, pp. 1082-1082
PREDICTIVE VALUE OF CLONALITY ANALYSIS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) - ASINGLE INSTITUTION STUDY
Authors: MACHPASCUAL S LEGARE RD LU D KROON M NEUBERG D STONE RM FREEDMAN AS NADLER LM GRIBBEN JG GILLILAND DG
Citation: S. Machpascual et al., PREDICTIVE VALUE OF CLONALITY ANALYSIS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) - ASINGLE INSTITUTION STUDY, Blood, 90(10), 1997, pp. 2626-2626
FAILURE OF IMMUNOLOGICAL PURGING IN MANTLE CELL LYMPHOMA ASSESSED BY POLYMERASE CHAIN-REACTION DETECTION OF MINIMAL RESIDUAL DISEASE
Authors: ANDERSEN NS DONOVAN JW BORUS JS POOR CM NEUBERG D ASTER JC NADLER LM FREEDMAN AS GRIBBEN JG
Citation: Ns. Andersen et al., FAILURE OF IMMUNOLOGICAL PURGING IN MANTLE CELL LYMPHOMA ASSESSED BY POLYMERASE CHAIN-REACTION DETECTION OF MINIMAL RESIDUAL DISEASE, Blood, 90(10), 1997, pp. 4212-4221
CELL-SURFACE ANTIGENS IN LEUKEMIAS AND LYMPHOMAS
Authors: FREEDMAN AS
Citation: As. Freedman, CELL-SURFACE ANTIGENS IN LEUKEMIAS AND LYMPHOMAS, Cancer investigation, 14(3), 1996, pp. 252-276
HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING FIRST REMISSION
Authors: FREEDMAN AS GRIBBEN JG NEUBERG D MAUCH P SOIFFER RJ ANDERSON KC PANDITE L ROBERTSON MJ KROON M RITZ J NADLER LM
Citation: As. Freedman et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH FOLLICULAR LYMPHOMA DURING FIRST REMISSION, Blood, 88(7), 1996, pp. 2780-2786
RESISTANCE OF MANTLE CELL LYMPHOMA BUT NOT B-CELL CLL TO IMMUNOLOGICAL PURGING
Authors: ANDERSEN NS BORUS J POOR C FREEDMAN AS PANDITE L NADLER LM GRIBBEN JG
Citation: Ns. Andersen et al., RESISTANCE OF MANTLE CELL LYMPHOMA BUT NOT B-CELL CLL TO IMMUNOLOGICAL PURGING, Blood, 88(10), 1996, pp. 1916-1916
ACTIVATION OF FOLLICULAR LYMPHOMA THROUGH CD40 UP-REGULATES BCL-X(L) THEREBY PROMOTING SURVIVAL
Authors: GHIA P BOUSSIOTIS VA MANIE S CARDOSO AA GRIBBEN JG FREEDMAN AS NADLER LM
Citation: P. Ghia et al., ACTIVATION OF FOLLICULAR LYMPHOMA THROUGH CD40 UP-REGULATES BCL-X(L) THEREBY PROMOTING SURVIVAL, Blood, 88(10), 1996, pp. 2672-2672
MOLECULAR CHARACTERIZATION OF SECONDARY NON-HODGKINS-LYMPHOMAS OCCURRING AFTER ABMT FOR LYMPHOMA
Authors: GRIBBEN JG ANDERSON NS FREEDMAN AS NADLER LM
Citation: Jg. Gribben et al., MOLECULAR CHARACTERIZATION OF SECONDARY NON-HODGKINS-LYMPHOMAS OCCURRING AFTER ABMT FOR LYMPHOMA, Blood, 88(10), 1996, pp. 2709-2709
POTENTIAL FOR CURE OF B-CELL CLL AND SLL - PROLONGED DISEASE-FREE SURVIVAL AND MOLECULAR REMISSIONS FOLLOWING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: BARTLETTPANDITE L GRIBBEN JG SOIFFER R ANDERSEN NS ANDERSON K FISHER DC FREEDMAN AS RITZ J NEUBERG D NADLER LM
Citation: L. Bartlettpandite et al., POTENTIAL FOR CURE OF B-CELL CLL AND SLL - PROLONGED DISEASE-FREE SURVIVAL AND MOLECULAR REMISSIONS FOLLOWING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 2718-2718
CD6 DEPLETED ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR NON-HODGKINS-LYMPHOMA
Authors: SOIFFER RJ NEUBERG D FREEDMAN AS ALYEA EP FISHER DC BARTLETTPANDITE L GRIBBEN J SCHLOSSMAN RL FREEMAN A ANDERSON KC NADLER LM RITZ J
Citation: Rj. Soiffer et al., CD6 DEPLETED ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 2719-2719
STIMULATION OF TYROSINE PHOSPHORYLATION AFTER LIGATION OF BETA-7 AND BETA-1 INTEGRINS ON HUMAN B-CELLS
Authors: MANIE SN ASTIER A WANG DK PHIFER JS CHEN JC LAZAROVITS AI MORIMOTO C FREEDMAN AS
Citation: Sn. Manie et al., STIMULATION OF TYROSINE PHOSPHORYLATION AFTER LIGATION OF BETA-7 AND BETA-1 INTEGRINS ON HUMAN B-CELLS, Blood, 87(5), 1996, pp. 1855-1861
EXPRESSION OF VASCULAR CELL-ADHESION MOLECULE-1 BY FOLLICULAR DENDRITIC CELLS
Authors: HUANG MJ OSBORN L SVAHN J SCHIFFER SB ELISEO L ZHOU LJ RHYNHART K BENJAMIN CD FREEDMAN AS
Citation: Mj. Huang et al., EXPRESSION OF VASCULAR CELL-ADHESION MOLECULE-1 BY FOLLICULAR DENDRITIC CELLS, Leukemia & lymphoma, 18(3-4), 1995, pp. 259-264
PCR DETECTION OF CLONAL IMMUNOGLOBULIN GENE REARRANGEMENT PREDICTS FOR RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA
Authors: ZWICKY CS FREEDMAN AS NADLER LM GRIBBEN JG
Citation: Cs. Zwicky et al., PCR DETECTION OF CLONAL IMMUNOGLOBULIN GENE REARRANGEMENT PREDICTS FOR RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA, Blood, 86(10), 1995, pp. 1154-1154
DISEASE-FREE STATUS AND ABSENCE OF PCR DETECTABLE MINIMAL RESIDUAL DISEASE SUGGESTS ERADICATION OF B-CLL FOLLOWING AUTOLOGOUS AND ALLOGENEIC BMT
Authors: GRIBBEN JG BARLETTPANDITE L PROVAN A ZWICKY C NEUBERG D MADDOCKS A FREEDMAN AS SOIFFER R RITZ J NADLER LM
Citation: Jg. Gribben et al., DISEASE-FREE STATUS AND ABSENCE OF PCR DETECTABLE MINIMAL RESIDUAL DISEASE SUGGESTS ERADICATION OF B-CLL FOLLOWING AUTOLOGOUS AND ALLOGENEIC BMT, Blood, 86(10), 1995, pp. 1815-1815
Risultati: 1-25 | 26-41